NasdaqCM - Delayed Quote USD
ENDRA Life Sciences Inc. (NDRA)
At close: November 15 at 4:00 PM EST
After hours: November 15 at 7:58 PM EST
Key Executives
Amounts are as of December 31, 2023 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.
| Name | Title | Pay | Exercised | Year Born |
|---|---|---|---|---|
| Mr. Alexander Y. Tokman | Acting CEO & Chairman | 67.6k | -- | 1962 |
| Mr. Michael Thornton Ph.D. | Chief Technology Officer | 279.24k | -- | 1968 |
| Dr. Jonathan Behr Ph.D. | Co-Founder | -- | -- | -- |
| Mr. Richard Jacroux | CFO & Secretary | -- | -- | 1967 |
| Mr. Steve Freeman | Human Resources Leader | -- | -- | -- |
| Mr. Ziad Rouag | Head of Regulatory & Clinical Affairs | -- | -- | -- |
ENDRA Life Sciences Inc.
- Sector:?
- Healthcare
- Industry:? Diagnostics & Research
- Full Time Employees:?
- 21
Description
ENDRA Life Sciences Inc. develops technologies to improve the capabilities of clinical diagnostic ultrasound. The company is developing thermo-acoustic enhanced ultrasound technology that uses radio frequency pulses to generate ultrasonic waves in tissue to create high-contrast images for use in the treatment of nonalcoholic fatty liver disease, as well as in tissue composition, temperature monitoring, vascular imaging, and tissue perfusion. It has a collaborative research agreement with General Electric Company. ENDRA Life Sciences Inc. was incorporated in 2007 and is based in Ann Arbor, Michigan.
Corporate Governance
ENDRA Life Sciences Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.
Upcoming Events
August 22, 2024 at 8:14 PM UTC
ENDRA Life Sciences Inc. Earnings Date
Recent Events
Related Tickers
APDN Applied DNA Sciences, Inc.
0.1620
-6.79%
STIM Neuronetics, Inc.
0.7100
-10.13%
MYNZ Mainz Biomed N.V.
0.2387
-4.52%
TTOO T2 Biosystems, Inc.
0.4970
-4.42%
ISPC iSpecimen Inc.
4.2000
-3.45%
CHEK Check-Cap Ltd.
0.7745
-5.55%
PSNL Personalis, Inc.
3.8900
-9.53%
PRPH ProPhase Labs, Inc.
0.7500
-0.19%
ACRS Aclaris Therapeutics, Inc.
2.0500
-5.96%
BDSX Biodesix, Inc.
1.3450
-3.93%